Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Hermann

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
Leukemia & Lymphoma|January 30, 2014
Phase III safety study of rituximab administered as a 90-minute infusion in patients with previously untreated diffuse large B-cell and follicular lymphomaShaker Dakhil, Robert Hermann, Marshall T Schreeder, et al.
Plos One|January 5, 2012
Reassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosisMichael Hecker, Brigitte Katrin Paap, Robert Hermann Goertsches, et al.
Diabetes/Metabolism Research and Reviews|July 29, 2009
Role of insulin autoantibody affinity as a predictive marker for type 1 diabetes in young children with HLA-conferred disease susceptibilityHeli Siljander, Taina Härkönen, Robert Hermann, et al.
Molecular and Cellular Biology|May 22, 2013
Interaction and antagonistic roles of NF-κB and Hes6 in the regulation of cortical neurogenesisLaurent Methot, Robert Hermann, Yeman Tang, et al.
Human Immunology|April 21, 2009
Association of CTLA4 but not ICOS polymorphisms with type 1 diabetes in two populations with different disease ratesKonstantinos Douroudis, Antti-Pekka Laine, Mirkka Heinonen, et al.
Journal of Autoimmunity|February 27, 2008
Reduced CD4+T cell activation in children with type 1 diabetes carrying the PTPN22/Lyp 620Trp variantJohanna Aarnisalo, Andras Treszl, Peter Svec, et al.
Clinical and Translational Science|April 2, 2025
Effect of Cladribine Tablets on the Pharmacokinetics of a Combined Oral Contraceptive in Pre-Menopausal Women With Relapsing Multiple SclerosisRobert Hermann, Kerstin Hellwig, Sumedh Gaikwad, et al.
Diabetes Care|September 16, 2009
From genetic risk awareness to overt type 1 diabetes: parental stress in a placebo-controlled prevention trialEszter Goldstein, Robert Hermann, Timo J Renfors, et al.
British Journal of Haematology|March 29, 2014
Open-label, single-arm, phase II study of enzastaurin in patients with follicular lymphomaLee Schwartzberg, Robert Hermann, Ian Flinn, et al.
Molecular Cancer Therapeutics|December 25, 2019
Targeting AXL and the DNA Damage Response Pathway as a Novel Therapeutic Strategy in MelanomaKarine Flem-Karlsen, Erin McFadden, Nasrin Omar, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
Leukemia & Lymphoma|January 30, 2014
Phase III safety study of rituximab administered as a 90-minute infusion in patients with previously untreated diffuse large B-cell and follicular lymphomaShaker Dakhil, Robert Hermann, Marshall T Schreeder, et al.
Plos One|January 5, 2012
Reassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosisMichael Hecker, Brigitte Katrin Paap, Robert Hermann Goertsches, et al.
Diabetes/Metabolism Research and Reviews|July 29, 2009
Role of insulin autoantibody affinity as a predictive marker for type 1 diabetes in young children with HLA-conferred disease susceptibilityHeli Siljander, Taina Härkönen, Robert Hermann, et al.
Molecular and Cellular Biology|May 22, 2013
Interaction and antagonistic roles of NF-κB and Hes6 in the regulation of cortical neurogenesisLaurent Methot, Robert Hermann, Yeman Tang, et al.
Human Immunology|April 21, 2009
Association of CTLA4 but not ICOS polymorphisms with type 1 diabetes in two populations with different disease ratesKonstantinos Douroudis, Antti-Pekka Laine, Mirkka Heinonen, et al.
Journal of Autoimmunity|February 27, 2008
Reduced CD4+T cell activation in children with type 1 diabetes carrying the PTPN22/Lyp 620Trp variantJohanna Aarnisalo, Andras Treszl, Peter Svec, et al.
Clinical and Translational Science|April 2, 2025
Effect of Cladribine Tablets on the Pharmacokinetics of a Combined Oral Contraceptive in Pre-Menopausal Women With Relapsing Multiple SclerosisRobert Hermann, Kerstin Hellwig, Sumedh Gaikwad, et al.
Diabetes Care|September 16, 2009
From genetic risk awareness to overt type 1 diabetes: parental stress in a placebo-controlled prevention trialEszter Goldstein, Robert Hermann, Timo J Renfors, et al.
British Journal of Haematology|March 29, 2014
Open-label, single-arm, phase II study of enzastaurin in patients with follicular lymphomaLee Schwartzberg, Robert Hermann, Ian Flinn, et al.
Molecular Cancer Therapeutics|December 25, 2019
Targeting AXL and the DNA Damage Response Pathway as a Novel Therapeutic Strategy in MelanomaKarine Flem-Karlsen, Erin McFadden, Nasrin Omar, et al.
Pageof 12